Krouse H A, Phung N D, Klaustermeyer W B
Ann Allergy. 1983 Jun;50(6):385-8.
The study was designed to measure the effect of inhaled beclomethasone on patients with severe symptomatic rhinosinusitis and nasal polyposis following 12 weeks of therapy. Only one of eight patients had improved nasal symptoms and a reduction in the degree of nasal obstruction. Except for an occasional patient intranasal beclomethasone in the recommended dosage is not effective in the management of chronic severe symptomatic rhinosinusitis.
该研究旨在测量吸入性倍氯米松对重度症状性鼻-鼻窦炎和鼻息肉患者进行12周治疗后的效果。八名患者中只有一名患者的鼻部症状有所改善,鼻塞程度减轻。除了偶尔有患者外,推荐剂量的鼻内倍氯米松对慢性重度症状性鼻-鼻窦炎的治疗无效。